Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death

[1]  P. Wester,et al.  Intracellular electrolytes in cardiac failure. , 2009, Acta medica Scandinavica. Supplementum.

[2]  T. Dyckner.  Serum magnesium in acute myocardial infarction. Relation to arrhythmias. , 2009, Acta medica Scandinavica.

[3]  M. Britton.  Diagnostic errors discovered at autopsy. , 2009, Acta medica Scandinavica.

[4]  S. Gottlieb.  Dead is dead—artificial definitions are no substitute , 1997, The Lancet.

[5]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[6]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[7]  L. Goldman,et al.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.

[8]  J. Daubert,et al.  Nonsustained Ventricular Tachycardia , 1997 .

[9]  W. Stevenson,et al.  Unsustained ventricular tachycardia--to treat or not to treat , 1996, The New England journal of medicine.

[10]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[11]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[12]  M. Rocco,et al.  Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. , 1996, JAMA.

[13]  G. Breithardt,et al.  Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. , 1996, Circulation.

[14]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[15]  S. Saksena,et al.  Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. , 1996, Progress in cardiovascular diseases.

[16]  G. Steinbeck,et al.  Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy. , 1996, Progress in cardiovascular diseases.

[17]  F. McAlister,et al.  Results of randomized clinical trials of magnesium--can a consensus be reached? , 1996, Coronary artery disease.

[18]  E. Friedmann,et al.  Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST). , 1996, Annals of epidemiology.

[19]  M. Pahor,et al.  A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS) , 1996, The American journal of cardiology.

[20]  S. Yusuf,et al.  Verapamil following uncomplicated myocardial infarction: promising, but not proven. , 1996, The American journal of cardiology.

[21]  M. Schoenfeld,et al.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. , 1996, Circulation.

[22]  D. M. Barr,et al.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. , 1996, Controlled clinical trials.

[23]  G. Breithardt,et al.  Implantable defibrillators are superior to d,I-sotalol for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease , 1996 .

[24]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[25]  R. Peters,et al.  Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. , 1995, British heart journal.

[26]  J. Ruskin,et al.  Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. , 1995, Circulation.

[27]  R. Campbell,et al.  Nonischemic Ventricular Tachycardia: Surgical or Medical Treatment? , 1995, Journal of cardiac surgery.

[28]  J. Guralnik,et al.  Long‐Term Survival and Use of Antihypertensive Medications in Older Persons , 1995, Journal of the American Geriatrics Society.

[29]  A. Gentile,et al.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). , 1995, American heart journal.

[30]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[31]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[32]  W E Boden,et al.  Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTE , 1995, The American journal of cardiology.

[33]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[34]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[35]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[36]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[37]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[38]  K. Kuck,et al.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). , 1994, American heart journal.

[39]  A. Bayés de Luna,et al.  Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. , 1993, The American journal of cardiology.

[40]  K. Teo,et al.  Critical review of the approaches to the prevention of sudden death. , 1993, The American journal of cardiology.

[41]  T. Taddei,et al.  Early out-of-hospital lidocaine administration decreases the incidence of primary ventricular fibrillation in acute myocardial infarction. , 1993, The Journal of emergency medicine.

[42]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[43]  Therapy Study Investigators.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.

[44]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[45]  A Fitton,et al.  Sotalol , 1993, Drugs.

[46]  D. Levy,et al.  Prognostic Implications of Asymptomatic Ventricular Arrhythmias: The Framingham Heart Study , 1992, Annals of Internal Medicine.

[47]  K. Rasmussen,et al.  Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial. , 1992, American heart journal.

[48]  S. Yusuf,et al.  Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. , 1992, Journal of the American College of Cardiology.

[49]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[50]  J. Elefteriades,et al.  Strategies in the surgical treatment of malignant ventricular arrhythmias. An 8-year experience. , 1992, Annals of surgery.

[51]  S. Fletcher,et al.  Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) , 1992, The Lancet.

[52]  S. Connolly,et al.  Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: the need for randomized trials. , 1992, The American journal of cardiology.

[53]  P. Schwartz,et al.  Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions , 1992 .

[54]  Y Pawitan,et al.  Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. , 1991, The American journal of cardiology.

[55]  R Peto,et al.  Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. , 1991, BMJ.

[56]  W. Mckenna,et al.  Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. , 1991, American heart journal.

[57]  S. Pinski,et al.  Survival in patients declining implantable cardioverter-defibrillators. , 1991, The American journal of cardiology.

[58]  S. Connolly,et al.  Post‐Myocardial Infarction Mortality in Patients With Ventricular Premature Depolarizations: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study , 1991, Circulation.

[59]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[60]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[61]  C. Furberg,et al.  Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. , 1991, The American journal of cardiology.

[62]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[63]  S. Saksena,et al.  Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias. , 1991, The American journal of cardiology.

[64]  M. Pfisterer,et al.  Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) , 1990, Journal of the American College of Cardiology.

[65]  J J Heger,et al.  Clinical features of amiodarone-induced pulmonary toxicity. , 1990, Circulation.

[66]  S. Nattel,et al.  What is an antiarrhythmic drug? From clinical trials to fundamental concepts. , 1990, The American journal of cardiology.

[67]  R. Kehoe,et al.  Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias. , 1990, The American journal of cardiology.

[68]  J. Anderson.  Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs. , 1990, The American journal of cardiology.

[69]  W. Stevenson,et al.  Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.

[70]  J. Johns,et al.  Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. , 1989, Journal of the American College of Cardiology.

[71]  N. Laird,et al.  Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. , 1989, JAMA.

[72]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[73]  J. Buring,et al.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction. , 1989, Circulation.

[74]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.

[75]  J. Langberg,et al.  Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. , 1989, Journal of the American College of Cardiology.

[76]  M. Davies,et al.  Community study of the causes of "natural" sudden death. , 1988, BMJ.

[77]  R. Collins,et al.  Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.

[78]  P. Tchou,et al.  Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. , 1988, Annals of internal medicine.

[79]  J. Gottdiener,et al.  Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrest. , 1988, The American journal of cardiology.

[80]  B. Hockings,et al.  Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. , 1987, The American journal of cardiology.

[81]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[82]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[83]  W. Kannel,et al.  An Epidemiological Perspective of Sudden Death 26-Year Follow-Up in the Framingham Study , 1984, Drugs.

[84]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[85]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[86]  R. Prescott,et al.  A controlled trial of sotalol for 1 year after myocardial infarction. , 1983, Circulation.

[87]  C. Hennekens,et al.  LIGNOCAINE PROPHYLAXIS IN ACUTE MYOCARDIAL INFARCTION: AN EVALUATION OF RANDOMISED TRIALS , 1981, The Lancet.

[88]  S. Rabkin,et al.  Relationship of ventricular ectopy in men without apparent heart disease to occurrence of ischemic heart disease and sudden death. , 1981, American heart journal.

[89]  M J Davies,et al.  Pathological view of sudden cardiac death. , 1981, British heart journal.

[90]  A. Moss,et al.  Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease. , 1980, Progress in cardiovascular diseases.

[91]  S. Rössner,et al.  Coronary Drug Project Research Group. , 1978, Atherosclerosis.

[92]  J. Goldberg,et al.  Ventricular premature beats and mortality after myocardial infarction. , 1977, The New England journal of medicine.

[93]  L. Cobb,et al.  Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. , 1975, The New England journal of medicine.

[94]  F. Epstein,et al.  Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study. , 1969, Annals of internal medicine.

[95]  K W Donald,et al.  Ventricular fibrillation complicating acute myocardial infarction. , 1968, Lancet.

[96]  A. Camm,et al.  Amiodarone in Long Term Prophylaxis , 2012, Drugs.

[97]  Eter,et al.  EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART FAILURE , 2000 .

[98]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[99]  C. T. Layton,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia , 1996 .

[100]  R. Winkle,et al.  Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. , 1996, Journal of the American College of Cardiology.

[101]  N. Mazur,et al.  [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome]. , 1994, Terapevticheskii arkhiv.

[102]  J. Bolander,et al.  Five-year follow-up of 589 patients treated with amiodarone. , 1993, American heart journal.

[103]  M. Arsenian.  Magnesium and cardiovascular disease. , 1993, Progress in cardiovascular diseases.

[104]  H. Greene.  Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. , 1993, The American journal of cardiology.

[105]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[106]  B. Singh.  Silent Myocardial Ischemia and Angina: Prevalence, Prognostic, and Therapeutic Significance , 1989 .

[107]  R. Winkle,et al.  Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias. , 1989, Journal of the American College of Cardiology.

[108]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[109]  C. Furberg,et al.  Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. , 1986, Journal of the American College of Cardiology.

[110]  H. Karppanen.  Epidemiological studies on the relationship between magnesium intake and cardiovascular diseases. , 1981, Artery.

[111]  H. Kesteloot,et al.  Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study. , 1979, Acta cardiologica. Supplementum.